Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica L Guzman

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Current Hematologic Malignancy Reports|April 9, 2013
Is minimal residual disease monitoring clinically relevant in adults with acute myelogenous leukemia?Karen-Sue B Carlson, Monica L Guzman
Oncoscience|January 5, 2017
The epichaperome: the power of many as the power of oneWang Tai, Monica L Guzman, Gabriela Chiosis
Antioxidants & Redox Signaling|December 4, 2012
Iron and reactive oxygen species: friends or foes of cancer cells?Laura M Bystrom, Monica L Guzman, Stefano Rivella
The New England Journal of Medicine|September 23, 2006
Cancer stem cellsCraig T Jordan, Monica L Guzman, Mark Noble
Journal of Aggression, Maltreatment & Trauma|March 6, 2018
Posttraumatic Growth and Sexual Violence: A Literature ReviewEmilio Ulloa, Monica L Guzman, Marissa Salazar, et al.
Cancer Letters|June 21, 2012
Acute myelogenous leukemia stem cells: from Bench to BedsideJ Felipe Rico, Duane C Hassane, Monica L Guzman
Frontiers in Oncology|May 26, 2023
Editorial: Measurable residual disease in hematologic malignanciesFrancesco Buccisano, Raffaele Palmieri, Monica L Guzman, et al.
Current Stem Cell Research & Therapy|February 27, 2019
Approaches to Targeting Cancer Stem Cells in Solid TumorsEloisi Caldas-Lopes, Alexandra Gomez-Arteaga, Monica L Guzman
Seminars in Immunology|May 6, 2026
Access to CAR-T therapy in Latin America: Barriers, gaps, and pathways forwardJorge Contreras, Lauren Herschbein, Nimisha Mathur, et al.
Frontiers in Pharmacology|March 9, 2023
Editorial: New immunotherapeutic and pharmacological targets and strategies in haematological malignanciesMark Thomas Shaw Williams, Yong-Mi Kim, Monica L Guzman
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Current Hematologic Malignancy Reports|April 9, 2013
Is minimal residual disease monitoring clinically relevant in adults with acute myelogenous leukemia?Karen-Sue B Carlson, Monica L Guzman
Oncoscience|January 5, 2017
The epichaperome: the power of many as the power of oneWang Tai, Monica L Guzman, Gabriela Chiosis
Antioxidants & Redox Signaling|December 4, 2012
Iron and reactive oxygen species: friends or foes of cancer cells?Laura M Bystrom, Monica L Guzman, Stefano Rivella
The New England Journal of Medicine|September 23, 2006
Cancer stem cellsCraig T Jordan, Monica L Guzman, Mark Noble
Journal of Aggression, Maltreatment & Trauma|March 6, 2018
Posttraumatic Growth and Sexual Violence: A Literature ReviewEmilio Ulloa, Monica L Guzman, Marissa Salazar, et al.
Cancer Letters|June 21, 2012
Acute myelogenous leukemia stem cells: from Bench to BedsideJ Felipe Rico, Duane C Hassane, Monica L Guzman
Frontiers in Oncology|May 26, 2023
Editorial: Measurable residual disease in hematologic malignanciesFrancesco Buccisano, Raffaele Palmieri, Monica L Guzman, et al.
Current Stem Cell Research & Therapy|February 27, 2019
Approaches to Targeting Cancer Stem Cells in Solid TumorsEloisi Caldas-Lopes, Alexandra Gomez-Arteaga, Monica L Guzman
Seminars in Immunology|May 6, 2026
Access to CAR-T therapy in Latin America: Barriers, gaps, and pathways forwardJorge Contreras, Lauren Herschbein, Nimisha Mathur, et al.
Frontiers in Pharmacology|March 9, 2023
Editorial: New immunotherapeutic and pharmacological targets and strategies in haematological malignanciesMark Thomas Shaw Williams, Yong-Mi Kim, Monica L Guzman
Pageof 12